Observational studyInternational journal of clinical oncology2025

Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study.

Taigo Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.